Thread
:
Phase 1 Anti-HER-2 Vaccine (APC8024) Shows Clinical Benefit
View Single Post
06-02-2003, 09:51 AM
#
1
Paul
Guest
Posts: n/a
Dendreon's Phase I Results of APC8024 -- anti-HER-2 Therapeutic Vaccine Demonstrate Ongoing Clinical Benefit in Women with Advanced Metastatic Breast Cancer as reported at the American Society of Clinical Oncology 2003 Annual Meeting
Paul